Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05650190 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Spectacle Lens Visual Acuity Assessments Study

Study acronym: CEDAR
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study completion date: Mar 31, 2026 to Dec 31, 2026v5
  2. Trial status: Completed to Active, Not Recruiting
    • Study completion date: Apr 5, 2023 to Mar 31, 2026
    v4
  3. Trial status: Active, Not Recruiting to Completed
    • Enrollment target: estimated 50 to confirmed 51
    • Study completion date changed from estimate of Apr 30, 2023 to Apr 5, 2023
    v3
  4. Trial status: Not Yet Recruiting to Active, Not Recruiting
    • Primary completion date changed from estimate of Mar 31, 2023 to Feb 10, 2023
    • Study completion date: Mar 31, 2023 to Apr 30, 2023
    • Start date changed from estimate of Dec 5, 2022 to Dec 8, 2022
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a two-arm parallel group, non-dispensing study. Participants will be existing active CYPRESS Extension (CPRO-1802-002) subjects. Subjects will undergo additional visual performance assessments.
Trial Details
NCT Number NCT05650190
Lead Sponsor SightGlass Vision, Inc.
Conditions
(from sponsor)		 Myopia, Myopia Progression, Juvenile Myopia
Related terms Myopia
Enrollment 51 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov